Find information on Constipation (C), including clinical documentation, medical coding, and healthcare best practices for managing irregular bowel movements and dyschezia. Learn about diagnosing and treating constipation, ICD-10 codes related to constipation, and effective strategies for patients experiencing infrequent or difficult bowel movements. This resource provides valuable insights for healthcare professionals, medical coders, and patients seeking information on constipation management.
Also known as
Constipation
Infrequent or difficult bowel movements.
Constipation, unspecified
Constipation without further specification.
Other abdominal pain
May include pain associated with constipation.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is constipation opioid-induced?
Yes
Is there documentation of drug resistance?
No
Is constipation related to a medical condition?
When to use each related code
| Description |
|---|
| Infrequent, difficult bowel movements. |
| Severe constipation with inability to pass stool or gas. |
| Hardened stool mass in the rectum or colon. |
Coding constipation without specifying chronic/acute or functional status risks inaccurate reimbursement and data analysis.
Failing to code underlying causes like medication side effects or neurological conditions leads to incomplete clinical picture.
Coding constipation as a symptom when it's the primary diagnosis can impact quality reporting and severity assessment.
Q: What are the most effective evidence-based strategies for managing chronic constipation in adult patients with comorbidities?
A: Managing chronic constipation in adults with comorbidities requires a multifaceted approach tailored to the individual patient. Evidence-based strategies include increasing dietary fiber intake (e.g., recommending a daily intake of 25-30 grams), ensuring adequate fluid intake, promoting regular physical activity, and establishing a consistent toileting routine. For patients with opioid-induced constipation, consider peripheral opioid antagonists like naloxegol or methylnaltrexone. For patients with slow-transit constipation, stimulant laxatives like bisacodyl or senna may be appropriate. Bulk-forming laxatives like psyllium can be helpful for increasing stool bulk. Osmotic laxatives such as polyethylene glycol can help soften the stool. Always consider potential drug interactions and contraindications based on the patient's comorbidities. Explore how integrating a bowel diary and patient education can improve adherence and outcomes. Learn more about the Rome IV criteria for diagnosing functional constipation.
Q: How can I differentiate between functional constipation and secondary constipation due to medication side effects in older adults?
A: Differentiating between functional and secondary constipation in older adults necessitates a thorough medication review and clinical assessment. Many medications, including anticholinergics, opioids, calcium channel blockers, and certain antidepressants, can contribute to secondary constipation. Ask about the onset of symptoms relative to medication initiation and consider a trial of discontinuation or dose reduction if appropriate, after consulting with the prescribing physician. Functional constipation, on the other hand, is often characterized by symptoms like infrequent bowel movements, straining, and hard stools without an identifiable underlying medical cause. Red flags suggesting a secondary cause include sudden changes in bowel habits, unintentional weight loss, rectal bleeding, and family history of colorectal cancer. Consider implementing a stepwise approach starting with conservative management, including lifestyle modifications and over-the-counter laxatives, before moving on to prescription medications. Explore the potential benefits of collaborating with a geriatrician or gastroenterologist for complex cases. Learn more about age-related changes in bowel function.
Patient presents with complaints consistent with constipation, characterized by infrequent bowel movements, straining during defecation, and hard or lumpy stools. The patient reports experiencing dyschezia and describes bowel movements occurring less than three times per week. Onset of symptoms is reported as [timeframe]. Associated symptoms include abdominal discomfort, bloating, and a sensation of incomplete evacuation. Patient denies any rectal bleeding, nausea, vomiting, or significant weight loss. Differential diagnoses considered include irritable bowel syndrome with constipation (IBS-C), pelvic floor dysfunction, and medication-induced constipation. Review of systems is otherwise unremarkable. Physical examination revealed normal bowel sounds and no palpable abdominal masses. Rectal examination revealed normal sphincter tone and no evidence of impaction. The patient's current medications include [list medications]. A review of the patient's medical history indicates [relevant past medical history, including relevant comorbidities like hypothyroidism or diabetes]. Diagnosis of functional constipation (ICD-10 code K59.0) is made based on Rome IV criteria. Plan includes increasing dietary fiber intake, encouraging fluid intake, and initiating a trial of over-the-counter osmotic laxative therapy with polyethylene glycol (PEG 3350). Patient education provided on lifestyle modifications for constipation management, including regular exercise and establishing a consistent toileting schedule. Follow-up scheduled in [timeframe] to assess treatment efficacy and adjust management plan as needed. Patient advised to return sooner if symptoms worsen or new symptoms develop.